AI assistant
Sending…
Anika Therapeutics, Inc. — Director's Dealing 2012
Apr 23, 2012
33997_dirs_2012-04-23_01165413-c9a9-4272-b54e-d0e9c12ef2b1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANIKA THERAPEUTICS INC (ANIK)
CIK: 0000898437
Period of Report: 2012-03-27
Reporting Person: LUPPINO FRANCESCO J (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-27 | Common Stock | M | 5979 | $5.01 | Acquired | 5979 | Direct |
Footnotes
F1: Exercise of stock appreciation rights granted on May 26, 2009 and that vested in four equal installments annually beginning May 26, 2010.
More from Anika Therapeutics, Inc.
Proxy Solicitation & Information Statement
2026
Jun 8
Proxy Solicitation & Information Statement
2026
Jun 1
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 23